跳至主要内容
临床试验/NCT01316393
NCT01316393已完成4 期

Clinical Evaluation of a Salivary Substitute and a Mucoprotective Product on Xerostomia in Head-and-neck Cancer Patients

Camurus AB2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Camurus AB
入组人数
20
试验地点
2
主要终点
OHIP questionaire health impact profile

研究概览

简要总结

In the present study with a randomized, cross-over, blind, placebo controlled design, the effects of a salivary substitute product and a new mucoprotective product with similar mechanisms of action but with different composition and characteristics will be evaluated in cancer patients suffering from xerostomia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must be at least 18 years of age.
  • The patient must have clinical symptoms of xerostomia (dry mouth) due to treatment of head and neck cancer
  • The patient must understand and consent in writing to the procedure.

排除标准

  • Do not meet the criterion for "dry mouth" regarding saliva secretion threshold values.
  • Known allergy to ingredients in the products to be used in the trial and/or allergy to soy, peanuts, citrus fruit,Yerba Santa or methyl parabene
  • Patients who are unable or unwilling to cooperate with study procedures.

结局指标

主要结局

OHIP questionaire health impact profile

时间窗: 7 days

Effect on oral health quality will be assessed after each treatment period

次要结局

未报告次要终点

研究者

发起方
Camurus AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验